The relation of protein C and protein S levels with cardiovascular risk in patients with diabetic neuropathy

Aktaş H. Ş., BASAT S., Demirbaş M. B., Sarikaya Z., Olçum G. G., Pınar E.

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, cilt.10, sa.4, ss.234-237, 2016 (Scopus)

Özet

Background This study was conducted to determine the clinically significance of protein C and protein S levels as a cardiovascular risk marker in patients with diabetic neuropathy. Methods We included 71 subjects. 50 of them were diabetics, 27 of them also had diabetic neuropathy(DN), 21 subjects were non diabetic. We evaluated these 3 group subjects’ protein C, protein S, fibrinogen, prothrombine time (PT), activated partial thromboplastine time (aPTT), total cholesterol, levels and Framingham Coronary Risk Score (FCRS). Results Non diabetic group's protein C levels were higher than patients with DN (p < 0.05) and diabetic patients without DN (p < 0.05). But there were no difference in terms of protein C levels between patients with DN and diabetic patients without DN. FCRS of control group was lower than diabetic subjects(p < 0.01). Conclusions We found that protein C and S levels were much lower in diabetic patients than non diabetics.There was no difference between diabetic patients with DN and diabetic patients without DN in terms of protein C and protein S levels. Further, we couldn't detect any finding that we can say protein C and Protein S levels can be used as a cardiovascular risk assessment marker in diabetic neuropathic patients.